Establishment of serological neutralizing tests using pseudotyped viruses for comprehensive detection of antibodies against all 18 lyssaviruses

Rabies is a fatal zoonotic, neurological disease caused by rabies lyssavirus (RABV) and other lyssaviruses. In this study, we established novel serological neutralizing tests (NT) based on vesicular stomatitis virus pseudotypes possessing all 18 known lyssavirus glycoproteins. Applying this system t...

Full description

Saved in:
Bibliographic Details
Published inJournal of Veterinary Medical Science Vol. 86; no. 1; pp. 128 - 134
Main Authors INOUE, Yusuke, KAKU, Yoshihiro, HARADA, Michiko, ISHIJIMA, Keita, KURODA, Yudai, TATEMOTO, Kango, VIRHUEZ-MENDOZA, Milagros, NISHINO, Ayano, YAMAMOTO, Tsukasa, PARK, Eun-sil, INOUE, Satoshi, MATSUU, Aya, MAEDA, Ken
Format Journal Article
LanguageEnglish
Published Japan JAPANESE SOCIETY OF VETERINARY SCIENCE 01.01.2024
Japan Science and Technology Agency
The Japanese Society of Veterinary Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Rabies is a fatal zoonotic, neurological disease caused by rabies lyssavirus (RABV) and other lyssaviruses. In this study, we established novel serological neutralizing tests (NT) based on vesicular stomatitis virus pseudotypes possessing all 18 known lyssavirus glycoproteins. Applying this system to comparative NT against rabbit sera immunized with current RABV vaccines, we showed that the current RABV vaccines fail to elicit sufficient neutralizing antibodies against lyssaviruses other than to those in phylogroup I. Furthermore, comparative NT against rabbit antisera for 18 lyssavirus glycoproteins showed glycoproteins of some lyssaviruses elicited neutralizing antibodies against a broad range of lyssaviruses. This novel testing system will be useful to comprehensively detect antibodies against lyssaviruses and evaluate their cross-reactivities for developing a future broad-protective vaccine.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0916-7250
1347-7439
1347-7439
DOI:10.1292/jvms.23-0463